Comerica Bank Vanda Pharmaceuticals Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Comerica Bank holds 1,007 shares of VNDA stock, worth $5,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,007

Previous 1,007 -0.0%

Holding current value

$5,125

Previous $5,000 20.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $86 - $115	-25 Reduced 2.42%	1,007 $4,000
Q3 2023 Nov 21, 2023	BUY	$4.28 - $6.57 $847 - $1,300	198 Added 23.74%	1,032 $4,000
Q2 2023 Aug 22, 2023	SELL	$5.9 - $6.95 $194,776 - $229,440	-33,013 Reduced 97.54%	834 $75,000
Q4 2022 Jan 26, 2023	SELL	$6.87 - $10.96 $65,326 - $104,218	-9,509 Reduced 21.93%	33,847 $0
Q3 2022 Oct 28, 2022	SELL	$9.44 - $11.76 $44,509 - $55,448	-4,715 Reduced 9.81%	43,356 $450,000
Q2 2022 Aug 02, 2022	BUY	$9.31 - $11.84 $3,398 - $4,321	365 Added 0.77%	48,071 $555,000
Q1 2022 Apr 27, 2022	BUY	$10.84 - $16.55 $12,791 - $19,529	1,180 Added 2.54%	47,706 $539,000
Q4 2021 Feb 18, 2022	SELL	$15.69 - $21.14 $877,714 - $1.18 Million	-55,941 Reduced 54.59%	46,526 $729,000
Q3 2021 Nov 22, 2021	BUY	$15.35 - $21.27 $774,699 - $1.07 Million	50,469 Added 97.06%	102,467 $1.76 Million
Q2 2021 Aug 26, 2021	SELL	$15.71 - $21.51 $53,414 - $73,134	-3,400 Reduced 6.14%	51,998 $1.12 Million
Q1 2021 Apr 28, 2021	SELL	$13.42 - $20.28 $28,920 - $43,703	-2,155 Reduced 3.74%	55,398 $832,000
Q4 2020 Jan 28, 2021	BUY	$9.77 - $13.81 $4,855 - $6,863	497 Added 0.87%	57,553 $756,000
Q3 2020 Oct 30, 2020	SELL	$9.32 - $12.02 $475 - $613	-51 Reduced 0.09%	57,056 $551,000
Q2 2020 Jul 31, 2020	BUY	$9.66 - $12.02 $52,395 - $65,196	5,424 Added 10.49%	57,107 $653,000
Q1 2020 May 01, 2020	BUY	$7.5 - $16.8 $12,067 - $27,031	1,609 Added 3.21%	51,683 $535,000
Q4 2019 Feb 07, 2020	BUY	$12.38 - $17.47 $804 - $1,135	65 Added 0.13%	50,074 $821,000
Q3 2019 Oct 31, 2019	BUY	$12.27 - $15.79 $4,969 - $6,394	405 Added 0.82%	50,009 $664,000
Q2 2019 Aug 02, 2019	SELL	$13.37 - $18.85 $29,922 - $42,186	-2,238 Reduced 4.32%	49,604 $0
Q1 2019 May 02, 2019	BUY	$17.59 - $31.05 $12,752 - $22,511	725 Added 1.42%	51,842 $0
Q4 2018 Feb 06, 2019	BUY	$18.97 - $31.47 $969,689 - $1.61 Million	51,117 New	51,117 $1.46 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $288M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account